China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
Revenue
13
3
3
3
3
2
Revenue Growth (YoY)
18%
50%
50%
50%
-25%
-71%
Cost of Revenue
12
2
2
3
3
1
Gross Profit
1
0
0
0
0
0
Selling, General & Admin
10
3
3
1
1
1
Research & Development
0
0
0
0
0
--
Operating Expenses
11
4
3
1
1
0
Other Non Operating Income (Expenses)
0
0
0
0
0
0
Pretax Income
-9
-4
-1
-1
-1
-1
Income Tax Expense
--
--
--
0
--
0
Net Income
-9
-4
-1
-1
-1
-1
Net Income Growth
80%
300%
0%
0%
0%
-80%
Shares Outstanding (Diluted)
0.13
0.13
0.07
0.03
0
0
Shares Change (YoY)
34,075%
34,075%
18,425%
9,675%
133%
33%
EPS (Diluted)
-69.31
-32.93
-25.73
-35.01
-2,575.75
-3,547.36
EPS Growth
-100%
-99%
-99%
-99%
-59%
-82%
Free Cash Flow
-18
-7
-2
-3
-5
0
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
7.69%
0%
0%
0%
0%
0%
Operating Margin
-69.23%
-133.33%
-66.66%
-33.33%
-33.33%
0%
Profit Margin
-69.23%
-133.33%
-33.33%
-33.33%
-33.33%
-50%
Free Cash Flow Margin
-138.46%
-233.33%
-66.66%
-100%
-166.66%
0%
EBITDA
-9
-4
-2
-1
-1
0
EBITDA Margin
-69.23%
-133.33%
-66.66%
-33.33%
-33.33%
0%
D&A For EBITDA
0
0
0
0
0
0
EBIT
-9
-4
-2
-1
-1
0
EBIT Margin
-69.23%
-133.33%
-66.66%
-33.33%
-33.33%
0%
Effective Tax Rate
--
--
--
0%
--
0%
Follow-Up Questions
What are China Pharma Holdings Inc's key financial statements?
According to the latest financial statement (Form-10K), Healthcare Triangle Inc has a total asset of $0, Net loss of $0
What are the key financial ratios for CPHI?
Healthcare Triangle Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is China Pharma Holdings Inc's revenue broken down by segment or geography?
Healthcare Triangle Inc largest revenue segment is Managed Services, at a revenue of 6,716,000 in the most earnings release.For geography, United States is the primary market for Healthcare Triangle Inc, at a revenue of 11,696,000.
Is China Pharma Holdings Inc profitable?
no, according to the latest financial statements, Healthcare Triangle Inc has a net loss of $0
Does China Pharma Holdings Inc have any liabilities?
no, Healthcare Triangle Inc has liability of 0
How many outstanding shares for China Pharma Holdings Inc?
Healthcare Triangle Inc has a total outstanding shares of 0